Founded in 1998 with visions of professional services, integrity conducts and passion of caring attitude, Giddi Pharma is a leading specialty pharmaceutical company in the Asia Pacific region. Giddi Pharma’s core business focus on commercial launch of orphan drugs, specialty products for pediatric genetic, metabolic and neurological diseases initially. After recruitment of talents and accumulation of experience, our services has now expanded to hematology, oncology, transplantation, and orthopedic surgery, as well as obstetrics and gynecology to better serve our patients and the medical community.
With commitment and collaboration, dedication and professionalism, robust capacity and flexibility, Giddi Pharma has successfully launched numerous products into local markets and accomplished superior growth promptly. That is how we earn the trust and business from partners worldwide to extend our portfolio. Our business partners include: Genzyme, BioMarin, Shire, Ipsen, Alexion, Cambridge Labs, etc.
Giddi Pharma offers One-stop-shopping comprehensive services to our collaborating partners by carefully planning and implementing every step, with optimal market growth in mind. Examples of our expertise are:
Pre-registration named patient import
Orphan drug, fast track and regular product registration
Dedicated regulatory department and medical professionals
Productive marketing & sales teams
Full spectrum coverage of markets: self-pay, National Health Insurance reimbursement application, hospital formulary listing,
Pharmacovigilance
Warehouse, distribution with cold-chain logistic capacity
In addition to the headquarter and warehouse in Taichung City, Giddi Pharma also has business offices in Taipei (Taiwan), Seoul (Korea), as well as Richardson, Texas (USA) reaching out to surrounding countries, and advancing to be your optimal partner in the Asia Pacific region. Please contact us for more information and we look forward to the opportunities to working with you!
Territory coverage map
Departments and Teams
Business Development Department
Giddi Pharma strongly believes in collaboration and team work to achieve synergism and mutual benefits between partners. The business development team identifies and assesses opportunities match its business model and portfolio strategy, then actively seeks for late stage niche products, pipeline candidates and collaborating partners domestically and internationally. Our in-depth knowledge and know how of local markets, plus proven track records of successes have won us trust and confidence from principals to award us one after another contract for long term collaboration. Depends upon the product characteristics, we formulate a realistic strategy for execution to quickly obtain marketing approval and distribute it through our sub-distributors or network alliance in region.
Sales and Marketing Department
Giddi Pharma features an experienced and energetic marketing and sales department, highly professional and effective, well established in local hospital, clinic and pharmacy distribution channels. The three sales teams in Taiwan are:
Orphan Drugs & Specialty Drugs Team: Giddi Pharma is the pioneer of Enzyme Replacement Therapy (ERT) in Taiwan, and has already successfully introduced more than ten rare disease drugs for commercial infusions. for: Gaucher's Disease, Mucopolysaccharidosis, Fabry disease, Wilson's Disease, Laron Syndrome, Pompe Disease, Rickets and Huntington's Disease.
Hematology, Oncology & Transplantation Team: offers numerous products for treatments, : Leukemia, Malignant Lymphoma, Hematopoietic-Cell Transplantation, Kidney and Heart Transplantations etc.
Since the establishment of Giddi Pharma, we have assisted many patients and hospitals by introducing specialty medications to satisfy their medical needs. We have also collaborated with global pharmaceutical companies to participate and conduct multi-national clinical trials to save time for future registration and advance local medical practice up to international standards.
Regulatory & Medical Department
Dedicated professional regulatory pharmacists in Giddi Pharma has superior experience, and detailed know how expertise in product registration to secure local marketing approval in shortest time possible for cost saving and quick launch. Every highly specialized staff in Medical Affairs Department not only has a wealth of knowledge on the clinical needs of physicians and patients, but also is familiar with local pharmaceutical regulations and global (USFDA and EMEA) reporting requirements.
Administration & Logistics Department
The Administration & Logistic Department provides comprehensive human resources, financial and logistics support, and is responsible for the quality control (QC) and quality assurance (QA) throughout custom importation, physical warehousing & entire local distribution, including transport and storage processes. With cold-chain capacity, our administration and logistics department is proud to pass the inspections and audits of several major bio-tech and pharmaceutical companies on regular basis, and conforms to those international pharmaceutical companies’ logistics standards.
Philosophy and Vision
President Chiang, Chin-Ying established the enterprise based on the principle of caring attitude toward the patients, as we believe that the top priority of medical products is in patient care. The orange color in the company logo symbolizes the spirit of Passion and Caring. The core management spirit for the enterprise is Professionalism, Passion, Integrity, Caring and Responsibility. Giddi Pharma believes that by offering premium products and professional knowledge with commitment to caring attitude will result in excellent market operation and enhance patients’ life quality, as well as improve the social welfare.
With solid strong roots in Taiwan, Giddi Pharma is actively extending its market territories in the Asia Pacific region. Meanwhile, Giddi Pharma is also collaborating with world renowned pharmaceutical companies to develop and market top notch medical products, biotech drugs and bio-surgical devices to become the partner of choice in the Asia Pacific Region.